Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Update

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the target of a large increase in short interest in November. As of November 15th, there was short interest totalling 6,400 shares, an increase of 23.1% from the October 31st total of 5,200 shares. Based on an average daily volume of 13,900 shares, the days-to-cover ratio is presently 0.5 days.

Integrated BioPharma Stock Performance

OTCMKTS INBP traded down $0.00 during trading hours on Monday, reaching $0.32. 20 shares of the company’s stock were exchanged, compared to its average volume of 10,622. The company’s 50-day moving average is $0.29 and its two-hundred day moving average is $0.24. Integrated BioPharma has a one year low of $0.16 and a one year high of $0.35. The company has a market capitalization of $9.63 million, a price-to-earnings ratio of 16.00 and a beta of 0.62.

Integrated BioPharma (OTCMKTS:INBP) last posted its quarterly earnings data on Friday, September 20th. The company reported $0.01 earnings per share for the quarter. Integrated BioPharma had a return on equity of 2.26% and a net margin of 0.84%. The business had revenue of $12.75 million for the quarter.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.